STRS Ohio’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.8K Buy
4,900
+1,400
+40% +$32.1K ﹤0.01% 2135
2026
Q2
$154K Buy
3,500
+600
+21% +$24K ﹤0.01% 1714
2026
Q1
$116K Buy
+2,900
New +$111K ﹤0.01% 1717
2025
Q3
– Sell
-2,300
Closed -$39.9K – 2309
2025
Q2
$39.9K Buy
+2,300
New +$30.1K ﹤0.01% 2058

Other funds holding SION

STRS Ohio's SION Position: Q3 2026 in Review

STRS Ohio increased its Sionna Therapeutics (SION) stake by 40% in Q3 2026, buying an estimated $32.1K and bringing the position to 4,900 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

STRS Ohio first reported a position in SION in Q2 2025 and has held it in 4 quarters since. The position peaked at $154K in Q2 2026. 29 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • STRS Ohio held 4,900 shares of Sionna Therapeutics worth $25.8K as of Q3 2026.
  • STRS Ohio bought 1,400 Sionna Therapeutics shares in Q3 2026, an estimated $32.1K.
  • Sionna Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #2135 holding.
  • STRS Ohio first reported a position in Sionna Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • STRS Ohio's Sionna Therapeutics position peaked at $154K in Q2 2026.
  • 29 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.